The NIDDK framework for translational research is expansive, ranging from bench to bedside all the way up to community-based interventions. But this extensive framework leaves some important gaps: (1) It sometimes disconnects laboratory from population research, impeding discovery of novel risk factors for diabetes and novel complications of diabetes or diabetes treatment;(2) It sometimes assumes that large trials have made treatment and prevention of diabetes matters of 'settled science', when in fact there are lingering controversies;(3) It generally ignores patient safety as a subject of investigation, despite persistent concerns about safety across a wide range of diabetes drugs and diabetes treatment strategies. (4) It sometimes ignores the underiying clinical complexity of patients with diabetes, especially those who are older or who have coexisting heart disease or cancer. At the Hopkins-UMD DRC, we have a track record of supporting research that fills these gaps, often with high-impact publications. We propose to construct a Healthcare &Population Science (HPS) Core that support research to fill these gaps and thereby serve a unique role nationally among the DRCs and CDTRs: The HPS Core will have 4 Sub-Cores: (1) Clinical, Molecular, and Pharmaco Epidemiology (Yeh, Segal) (2) Clinical Trials (Brancati, Davis);3) Behavior &Psychometrics Sub-Core (Hill-Briggs);(4) Biostatistics Sub-Core (Wang). Themes of special interest will include: Health Disparities;Evidence-Based Medicine (including Systematic reviews and Meta-analysis);Novel Risk Factors and Complications;Healthcare interventions (including Population Health and Disease management;Bariatric Surgery;Personalized Medicine;Tailored behavioral interventions;and Drug Safety.
The HPS Core will support research directly relevant to patient care, clinical decision-making, guideline development, and [Dost-marketing drug surveillance. It will also create a bridge from mechanistically oriented laboratory research and physiologic research in humans to population science.
|Crane, Janet L; Xian, Lingling; Cao, Xu (2016) Role of TGF-Î² Signaling in Coupling Bone Remodeling. Methods Mol Biol 1344:287-300|
|Houtz, Jessica; Borden, Philip; Ceasrine, Alexis et al. (2016) Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion. Dev Cell 39:329-345|
|Nicholas, Cari; Davis, Joseph; Fisher, Thomas et al. (2016) Maternal Vitamin D Deficiency Programs Reproductive Dysfunction in Female Mice Offspring Through Adverse Effects on the Neuroendocrine Axis. Endocrinology 157:1535-45|
|Li, Zhu; Frey, Julie L; Wong, G William et al. (2016) Glucose Transporter-4 Facilitates Insulin-Stimulated Glucose Uptake in Osteoblasts. Endocrinology 157:4094-4103|
|Hou, Ching-Wen; Mohanan, Vishnu; Zachara, Natasha E et al. (2016) Identification and biological consequences of the O-GlcNAc modification of the human innate immune receptor, Nod2. Glycobiology 26:13-8|
|Zoch, Meredith L; Clemens, Thomas L; Riddle, Ryan C (2016) New insights into the biology of osteocalcin. Bone 82:42-9|
|Chopra, Swati; Polotsky, Vsevolod Y; Jun, Jonathan C (2016) Sleep Apnea Research in Animals. Past, Present, and Future. Am J Respir Cell Mol Biol 54:299-305|
|Lodh, Sukanya; Hostelley, Timothy L; Leitch, Carmen C et al. (2016) Differential effects on Î²-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes. Hum Mol Genet 25:57-68|
|Pho, H; Hernandez, A B; Arias, R S et al. (2016) The effect of leptin replacement on sleep-disordered breathing in the leptin-deficient ob/ob mouse. J Appl Physiol (1985) 120:78-86|
|Bozzi, Laura M; Mitchell, Braxton D; Lewis, Joshua P et al. (2016) The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin. Curr Vasc Pharmacol 14:116-24|
Showing the most recent 10 out of 678 publications